Infermedica, a Poland-founded digital health company that offers AI-powered solutions for symptom analysis and patient triage, raised $30 million in Series B funding, the startup has raised $45 million in total to date.
The round was led by One Peak, with participation from previous investors Karma Ventures, European Bank for Reconstruction and Development, Heal Capital, and Inovo Venture Partners.
The investment will be used to further develop the company’s Medical Guidance Platform and add new modules to cover the full primary care journey.
Company: Infermedica Inc.
Round: Series B
Funding Month: January 2022
Lead Investors: One Peak
Additional Investors: Karma Ventures, European Bank for Reconstruction and Development, Heal Capital, and Inovo Venture Partners
Company Website: https://infermedica.com/
Software Category: AI-based medical guidance platform
About the Company: Founded in 2012, Infermedica aims to make it easier for doctors to pre-diagnose, triage, and direct their patients to appropriate medical services. The company offers a preliminary diagnosis symptom checker, an AI-driven software that supports call operators making timely triage recommendations, and an application programming interface that allows users to build customized diagnostic solutions from scratch. The company’s mission is to make primary care more accessible and affordable by introducing automation into healthcare. Infermedica has created a B2B platform for health systems, payers, and providers that automates patient triage, the intake process, and follow-up after a visit. Since its launch, Infermedica is being used in more than 30 countries in 19 languages and has completed more than 10 million health checks.